EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:3395 - carbidopa

Default Structure
ChEBI IDCHEBI:3395
ChEBI Namecarbidopa
Stars
DefinitionThe hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens α- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.
Secondary ChEBI IDCHEBI:212626
Last Modified29 April 2010
DownloadsMolfile
FormulaC10H14N2O4.H2O
Net Charge0
Average Mass244.247
Monoisotopic Mass244.10592
SMILESC[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O
InChIInChI=1S/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1
InChIKeyQTAOMKOIBXZKND-PPHPATTJSA-N
Roles Classification
Chemical Role:
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Biological Roles:
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor  An EC 4.1.1.* (carboxy-lyase) inhibitor that interferes with the action of aromatic-L-amino-acid decarboxylase (EC 4.1.1.28).
dopaminergic agent  A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
Applications:
antiparkinson drug  A drug used in the treatment of Parkinson's disease.
dopaminergic agent  A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
antidyskinesia agent  Any compound which can be used to treat or alleviate the symptoms of dyskinesia.
ChEBI Ontology
Outgoing Relation(s)
carbidopa (CHEBI:3395) has part carbidopa (anhydrous) (CHEBI:39585)
carbidopa (CHEBI:3395) has role antidyskinesia agent (CHEBI:66956)
carbidopa (CHEBI:3395) has role antiparkinson drug (CHEBI:48407)
carbidopa (CHEBI:3395) has role dopaminergic agent (CHEBI:48560)
carbidopa (CHEBI:3395) has role EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor (CHEBI:59321)
carbidopa (CHEBI:3395) is a catechols (CHEBI:33566)
carbidopa (CHEBI:3395) is a hydrate (CHEBI:35505)
carbidopa (CHEBI:3395) is a hydrazines (CHEBI:24631)
carbidopa (CHEBI:3395) is a monocarboxylic acid (CHEBI:25384)
IUPAC Name 
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid—water (1/1)
INN  Source
carbidopaChemIDplus
Synonyms  Source
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrateChEBI
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrateChEBI
carbidopa hydrateChEBI
carbidopa monohydrateDrugBank
carbidopum monohydricumChEBI
(S)-(−)-carbidopa hydrateChEBI
Manual XrefsDatabases
D00558KEGG DRUG
DB00190DrugBank
DE2062285Patent
DE2062332Patent
GB940596Patent
US3462536Patent
Registry NumbersSources
CAS:38821-49-7ChemIDplus
Citations